850081P

Monolyso Heart CA

Avanti Research^™ - A Croda Brand 850081P, powder

• Sinónimos: monolysocardiolipin (Heart, Bovine) (sodium salt)
• Número de CAS: 383907-65-1
• Código UNSPSC: 12352211
• NACRES: NA.25

Propiedades

• Análisis: >99% (TLC)
• formulario: powder
• envase: pkg of 1 × 10 mg (850081P-10mg)
• fabricante / nombre comercial: Avanti Research^™ - A Croda Brand 850081P
• tipo de lípido: phosphoglycerides
• Condiciones de envío: dry ice
• temp. de almacenamiento: −20°C
• cadena SMILES: O=P([O-])(OC[C@]([H])(O)COC(CCCCCCC/C=C\C/C=C\CCCCC)=O)OCC([H])(O)COP([O-])(OC[C@]([H])(OC(CCCCCCC/C=C\C/C=C\CCCCC)=O)COC(CCCCCCC/C=C\C/C=C\CCCCC)=O)=O.[Na+].[Na+]

Descripción

Descripción general

Monolysocardiolipin (MLCL) is a class of phospholipid related to cardiolipin. MLCL is a triacylated phospholipid, uncommon in bacterial or eukaryotic membranes. MLCL is prepared from cardiolipin by the hydrolysis action of phospholipase A2 (PLA2).

Aplicación

Monolyso Heart CA is suitable for use:

• as substrate for the synthesis of cardiolipin by the enzyme acyl-CoA:lysocardiolipin acyltransferase (ACLAT1)
• as substrate for the assay of mitochondrial monolysocardiolipin acyltransferase (MLCL AT) activity
• in the preparation of affinity resin MLCL-adriamycin-agarose for the purification of MLCL AT

Acciones bioquímicas o fisiológicas

Monolysocardiolipin (MLCL) is a substrate for the biosynthesis of cardiolipin in heart by the activity of MLCL acyltransferase. MLCL is a marker for Barth syndrome. MLCL is implicated in apoptosis.

Envase

5 mL Clear Glass Sealed Ampule (850081P-10mg)

Información legal

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• Código de clase de almacenamiento: 11 - Combustible Solids
• Clase de riesgo para el agua (WGK): WGK 3